Mohammad Bahmanyar

  • Citations Per Year
Learn More
Anaplastic multiple myeloma (AMM) is a rare morphologic variant of MM with adverse prognosis. The underlying molecular cytogenetic abnormalities are poorly understood. We investigated 11 patients with AMM for myeloma associated cytogenetic aberrations and compared with 188 non-anaplastic MM using fluorescent in situ hybridization. Of the 11 AMM patients(More)
The aim of this study is to assess nucleoprotein expression of IKZF1/3 in patients with relapsed/refractory multiple myeloma (MM) who received lenalidomide-based therapy and correlated them with their clinical outcomes. A total of 50 patients diagnosed with MM were entered in the study with the median follow-up of 86.4 months. By immunohistochemistry (IHC),(More)
A 64-year-old previously healthy male presented to clinic with increased shortness of breath. Blood work showed pancytopenia, bone marrow (BM) aspiration showed dysplasia in erythroid, granulocytic and megakaryocytic lineage cells, and less than 5% blasts. Cytogenetic study revealed a complex karyotype [45, XY,(More)
  • 1